Keros Therapeutics, Inc. Other Current Assets
Keros Therapeutics, Inc. (KROS) had Other Current Assets of $760.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-03
- 2026-06-30: Other Assets, Current $760.00K.
- 2026-03-31: Other Assets, Current $1.03M.
- 2025-12-31: Other Assets, Current $2.40M.
- 2025-09-30: Other Assets, Current $2.65M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $760.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $1.03M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.40M 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $2.65M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.52M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $2.94M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.45M 10-K · filed 2026-03-04 | $1.48M 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.39M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $582.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $616.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.00M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $319.00K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $376.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $515.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $276.00K 10-K · filed 2024-02-28 | $180.00K 10-K · filed 2023-03-03 |
| 2022-09-30 | $745.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $466.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $251.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $210.00K 10-K · filed 2023-03-03 | $340.00K 10-K · filed 2022-03-09 |
| 2021-09-30 | $313.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $290.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $265.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $160.00K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $130.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $279.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $335.00K 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $215.00K 10-K · filed 2021-03-25 | $231.00K 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |